There is provided a 5-thio-.beta.-D-glucopyranoside compound of the following formula, which has an inhibitory effect on SGLT2 activity, or a pharmaceutically acceptable salt thereof or a hydrate thereof. There is also provided a pharmaceutical preparation, particularly a prophylactic or therapeutic agent for diabetes, diabetes-related diseases or diabetic complications, which comprises such a compound as an active ingredient. 1

 
Web www.patentalert.com

< Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments

< Distal portion of an endoscopic delivery system

> Techniques for selective channel processing and data retention in an implantable medical device

> Method and product

~ 00210